PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 6, 2026American Economic Journal Economic Policy0 citations

Medical Technology and Life Expectancy: Evidence from the Antitoxin Treatment of Diphtheria

View Full Paper
PAPhilipp AgerCHC Pilebaek HansenPLPeter Z. Lin

Key Points

  • This research aims to examine the effect of diphtheria antitoxin on life expectancy in Massachusetts during the early twentieth century.
  • Analyzed municipality-level data on antitoxin distribution
  • Reviewed over 1.5 million death certificates from 1880 to 1914
  • Examined historical health transition linked to antitoxin availability
  • Antitoxin treatment significantly increased life expectancy at young ages
  • Findings suggest a greater role of public health policy in improving life expectancy
  • Demonstrated the impact of the first effective medical treatment for infectious diseases

Abstract

We examine the impact of the free supply of diphtheria antitoxin, the first effective medical treatment for an infectious disease, on the historical health transition in Massachusetts. Using newly collected municipality-level data on the distribution of antitoxin and information from over 1.5 million death certificates from 1880 to 1914, we find that the rapid availability of antitoxin treatment significantly increased life expectancy at young ages. Our findings suggest that medicine, combined with an effective public health policy, played a more important role in improving life expectancy in the early twentieth century than previously thought. (JEL H75, I12, I18, J13, N31)

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Ager et al. (2026) studied this question.

synapsesocial.com/papers/69faa28f04f884e66b5332bchttps://doi.org/10.1257/pol.20240087
Ask AI
Helpful
Bookmark
Share
View Full Paper